Intratumoral Injection of IP-001 Following Thermal Ablation in Patients With Advanced Solid Tumors. A Multicenter Phase Ib/IIa Trial With Expansion Cohorts in Melanoma and Soft Tissue Sarcoma Patients.
Latest Information Update: 10 Jun 2019
At a glance
- Drugs Dexfenfluramine (Primary)
- Indications Malignant melanoma; Soft tissue sarcoma; Solid tumours
- Focus Adverse reactions; Therapeutic Use
Most Recent Events
- 10 Jun 2019 New trial record